Price
1,786.2
-0.31%52W Range
Market Cap
₹30,646.40 Cr
Traded: ₹16.10 Cr (0.05%) 0.0x
Free Float: ₹4,903.42 Cr (0.33% of FF traded)
Volume · 60D trend
90.18 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +42.0% | +46.0% | -- | +21.0% | Stable |
| ROE | -- | +39.0% | +37.0% | -- | -- | Decelerating |
| Return | -- | -- | -- | +17.0% | -- | -- |
| Profit | -- | +34.0% | +30.0% | -- | +41.0% | Stable |
Quarterly Results
Jun 2024
Mar 2024
Dec 2023
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 894 | 858 | 815 | 781 | 740 | 724 | 657 | 643 | 640 | 620 | 567 |
| Expenses | 604 | 563 | 536 | 511 | 502 | 498 | 476 | 454 | 467 | 494 | 405 |
| Operating Profit | 290 | 295 | 279 | 270 | 238 | 226 | 181 | 189 | 173 | 126 | 162 |
| OPM % | 32.0% | 34.0% | 34.0% | 35.0% | 32.0% | 31.0% | 28.0% | 29.0% | 27.0% | 20.0% | 29.0% |
| Other Income | 6 | 5 | 6 | 4 | 3 | 3 | 27 | 5 | 4 | 15 | 6 |
| Interest | 10 | 13 | 23 | 16 | 18 | 21 | 21 | 22 | 26 | 32 | 26 |
| Depreciation | 34 | 34 | 32 | 30 | 28 | 28 | 28 | 28 | 28 | 27 | 19 |
| Profit Before Tax | 251 | 253 | 229 | 228 | 195 | 180 | 160 | 144 | 122 | 81 | 124 |
| Tax % | 23.0% | 19.0% | 20.0% | 21.0% | 22.0% | 18.0% | 19.0% | 21.0% | 22.0% | 21.0% | 18.0% |
| Net Profit | 194 | 206 | 183 | 181 | 152 | 148 | 130 | 113 | 95 | 64 | 102 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 11.3 | 12.0 | 10.7 | 10.5 | 8.8 | 8.6 | 7.6 | 6.6 | 5.6 | 3.7 | 5.9 |
| Sales Growth (YoY) | 20.8% | 18.5% | 24.1% | 21.5% | 15.6% | 16.8% | 15.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 4.2% | 5.3% | 4.3% | 5.5% | 2.2% | 10.2% | 2.2% | 0.5% | 3.2% | 9.3% | -- |
| OP Growth (YoY) | 21.8% | 30.5% | 54.1% | 42.9% | 37.6% | 79.4% | 11.7% | -- | -- | -- | -- |
| OP Growth (QoQ) | -1.7% | 5.7% | 3.3% | 13.4% | 5.3% | 24.9% | -4.2% | 9.2% | 37.3% | -22.2% | -- |
| Profit Growth (YoY) | -- | 39.0% | 41.0% | 60.0% | 59.0% | 132.0% | 28.0% | -- | -- | -- | -- |
| EPS Growth (YoY) | 27.9% | 39.4% | 41.3% | 59.8% | 58.5% | 131.4% | 27.3% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -5.9% | 12.4% | 1.4% | 19.3% | 2.6% | 13.9% | 14.7% | 18.3% | 49.7% | -37.4% | -- |
| OP Margin | 32.4% | 34.4% | 34.2% | 34.6% | 32.2% | 31.2% | 27.6% | 29.4% | 27.0% | 20.3% | 28.6% |
| Net Margin | 21.7% | 24.0% | 22.4% | 23.2% | 20.5% | 20.4% | 19.8% | 17.6% | 14.8% | 10.3% | 18.0% |
| Material Cost % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Employee Cost % | 51.0% | 49.0% | 50.0% | 52.0% | 54.0% | 53.0% | 58.0% | 57.0% | 56.0% | 61.0% | 51.0% |
| P/S | 9.15 | 10.09 | 9.39 | 8.13 | -- | -- | -- | -- | -- | -- | -- |
| P/E | 40.14 | 44.66 | 43.34 | 38.72 | -- | -- | -- | -- | -- | -- | -- |
| P/B | 13.68 | 14.38 | 12.82 | 10.53 | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Enclosed is disclosure of newspaper publication.
Ref: Our intimation dated August 11, 2026 for Schedule of Analyst/ Institutional Investor Meet. Sub: Change in Schedule of Analyst/ Institutional Investor Meet. In continuation of ....
Ref: Our intimation dated August 11, 2026 for Schedule of Analyst/ Institutional Investor Meet. Sub: Schedule of Analyst/ Institutional Investor Meet - Update. In continuation to ....
Transcript of the Q1 FY 2026-27 Earnings Conference Call. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed ....
In terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you ....
In terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you ....
Enclosed is the newspaper publication of unaudited financial results of the Company for the quarter ended June 30, 2026.
Enclosed is postal ballot voting results and scrutinizer''s report.
Enclosed is outcome of postal ballot, voting results and scrutinizer''s report.
The Unaudited Standalone and Consolidated Financial results for the quarter ended June 30, 2026 is enclosed.
Enclosed.
Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we hereby inform that the Board of Directors of Inventurus Knowledge ....
Enclosed is intimation about update on additional investment in WWMG MSO LLC .
Enclosed is intimation about update on acquisition.
Attached herewith is Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Enclosed is the Press Release.
Enclosed is the intimation about completion of acquisition of TruBridge.
Enclosed is the Newspaper Advertisement confirming dispatch of Postal Ballot Notice.
Enclosed is the Postal Ballot Notice.
Enclosed is the disclosure about update on acquisition.
Enclosed is the intimation with respect to update on acquisition.
Enclosed is the intimation of grant of employee stock options under Employee Stock Option Plan 2022.
Enclosed is the disclosure with respect to update on acquisition.
Enclosed is Investors'' FAQs with respect to annoucement additional investment in IKS WWMG MSO LLC
Enclosed is the Press Release titled " IKS Health Delivers $12 Million in Annual Cash Impact for Coding Foundation at Axia Women''s Health."
Disclosure with respect to Additional Investment in IKS WWMG MSO LLC by Inventurus Knowledge Solutions Inc. is enclosed.
Intimation with respect to Closure of Trading Window in connection with Unaudited Financial Results for the quarter ended June 30, 2026.
Enclosed is Press Release issued by CARE Ratings Limited in relation to Rating assigned to the Company.
Enclosed is intimation regarding credit rating assigned by CARE Ratings Limited.
Attached herewith is the intimation of grant of employee stock options under Employee Stock Plan 2022.
Enclosed is the schedule of analyst/institutional investor meet.
Enclosed is Scrutinizer''s Report on Postal Ballot e-voting.
Enclosed is outcome of postal ballot.
Enclosed is Annual Secretarial Compliance Report for the year ended March 31, 2026.
In terms of Regulation 30(6) read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you ....
Earnings Call Transcript is enclosed.
Newspaper Publication of Audited Financial Results for the quarter and year ended March 31, 2026 is enclosed.
Enclosed is the intimation with respect to audio recording of the Earnings Conference Call held on May 14, 2026.
Enclosed is the update intimation under Regulation 30(7) SEBI LODR Regulations with respect to Acquisition of Arai Solutions Private Limited.
Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), we hereby inform that the Board of Directors of Inventurus Knowledge ....
Investor Presentation is enclosed.
Disclosure with respect to re-appointment of Internal Auditor is enclosed.
Disclosure with respect to Acquisition of ARAI Solutions Private Limited is enclosed.
The Audited Standalone and Consolidated Financial Results and the Report issued by Price Waterhouse Chartered Accountants LLP, Statutory Auditors on the said Financial Results are enclosed. ....
Press Release is enclosed.
Press Release dated May 13, 2026 titled "IKS Health announces Acquisition ARAI Solutions, an AI Management and Technology Company."
Disclosure with respect to change in Senior Management Personnel is enclosed.
Revised intimation for Earnings Conference Call on Q4 FY 2025-26 Results - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('SEBI ....
Enclosed is the Earnings Conference Call Intimation.
Inventurus Knowledge Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the audited ....
Annual Reports
12025
Concalls
6Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Jul 2025
31 Jul 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Held by ETFs
15 ETFs hold iks · sorted by weight
Held by Mutual Funds
43 schemes hold iks · sorted by weight